4//SEC Filing
Chen Leon 4
Accession 0001209191-21-035535
CIK 0001549595other
Filed
May 23, 8:00 PM ET
Accepted
May 24, 7:48 PM ET
Size
6.2 KB
Accession
0001209191-21-035535
Insider Transaction Report
Form 4
Chen Leon
Director
Transactions
- Award
Director Stock Option (right to buy)
2021-05-06+17,500→ 17,500 totalExercise: $27.38Exp: 2031-05-05→ Common Stock (17,500 underlying)
Footnotes (2)
- [F1]The stock option vests as to 100% of the award on the earlier of (a) the date of the next annual meeting of the Issuer's stockholders and (b) May 6, 2022, in each case, subject to the Reporting Person's provision of service to the Issuer on such vesting date.
- [F2]The Reporting Person is a partner of The Column Group which invests through The Column Group II, LP ("TCG II LP"), Ponoi Capital, LP ("Ponoi LP") and Ponoi Capital II, LP ("Ponoi II LP," and together with TCG II LP and Ponoi LP, the "Funds"), among other entities. Under the partnership agreements of the Funds, the Reporting Person is deemed to hold the stock option for the economic benefit of the Funds. The Funds may be deemed indirect beneficial owners of the stock option. The Reporting Person disclaims beneficial ownership of the stock option except to the extent of his pecuniary interest therein.
Documents
Issuer
Nurix Therapeutics, Inc.
CIK 0001549595
Entity typeother
Related Parties
1- filerCIK 0001752432
Filing Metadata
- Form type
- 4
- Filed
- May 23, 8:00 PM ET
- Accepted
- May 24, 7:48 PM ET
- Size
- 6.2 KB